Solange Peters, MD, PhD from the University of Lausanne, Lausanne, Switzerland discusses the conference highlights at the annual meeting of European Lung Cancer Conference (ELCC) 2017 in Geneva, Switzerland. Dr Peters describes three points that she found particularly interesting; managing toxicities, combination immunotherapy, and using immunotherapy in PDL1 negative patients.